Rituxan

Roche’s GA101 Met Goals in Stage One of Trial to Replace Rituxan
Bloomberg
Thu, 01/31/13 - 10:41 am
Roche
GA101
Rituxan
chronic lymphocytic leukemia
Boehringer Testing Copy of Rituxan in Type of Lymphoma
Bloomberg
Wed, 01/30/13 - 10:57 am
Rituxan
Boehringer Ingelheim
Roche
non-Hodgkin's lymphoma
Good News For Biogen's $7 Billion Rituxin: Copying Drugs Bio Drugs Ain't Easy
Forbes
Thu, 10/11/12 - 05:45 pm
Biogen Idec
Rituxan
Genentech
Roche Faces New Foe as Boehringer Plans a Rituxan Copy
Bloomberg
Fri, 10/5/12 - 11:27 am
Roche
Rituxan
Boehringer Ingelheim
rheumatoid arthritis
Roche expects to keep Rituxan monopoly until 2015
Fierce Pharma
Fri, 09/7/12 - 12:22 pm
Roche
cancer
Rituxan
biosimilars
Rituxan And Its Biosimilar Competitors
Seeking Alpha
Mon, 07/30/12 - 10:28 am
Rituxan
BiogenIdec
Halozyme
Hospira
iBio
Lonza
Merck
Novartis
Pfizer
Roche
Spectrum Pharmaceuticals
cancer
Viropro
Teva Pharmaceuticals
Sanofi Loses Appeal in Roche Suit Over Rituxan, Avastin
Bloomberg
Fri, 03/23/12 - 11:30 am
lawsuits
Sanofi
Roche
Rituxan
Avastin
Genentech
Biogen Idec
Fake Avastin may not be the only counterfeit on doctors' shelves
Fierce Pharma
Thu, 02/16/12 - 11:44 am
Avastin
Roche
drug counterfeiting
Herceptin
Rituxan
Roche Pays $20M To Settle Whistleblower Lawsuit
Pharmalot
Fri, 12/2/11 - 11:20 am
Roche
whistleblower lawsuits
Rituxan
Medicare
Medicaid
Biogen to take $50M hit from lymphoma drug dispute
Bizjournals.com
Fri, 06/24/11 - 09:21 am
lymphoma
Biogen Idec
Rituxan
FDA approves Genentech vasculitis treatment
Bizjournals.com
Wed, 04/20/11 - 12:04 pm
FDA
Genentech
vasculitis
Rituxan
FDA Approves Rituxan for First-Line Maintenance Use in Follicular Lymphoma
BusinessWire
Sat, 01/29/11 - 11:24 am
Roche Group
Biogen Idec
follicular lymphoma
Rituxan
Biosimilars: Empty Threats?
InVivo
Tue, 01/18/11 - 11:58 am
biosimilars
Novartis
Sandoz
Roche
Rituxan
Novartis plans trial of equivalent to Roche drug
Marketwatch
Mon, 01/10/11 - 12:16 pm
Roche
Novartis
biosimilars
Rituxan
Sandoz
rheumatoid arthritis
rituximab
Spectrum Pharma Jumps in With the Big Dogs
Motley Fool
Thu, 01/6/11 - 07:40 am
Spectrum Pharmaceuticals
Roche
biosimilars
Biogen Idec
Rituxan
Genentech: positive results from cancer drug study
Yahoo/AP
Mon, 12/6/10 - 11:00 am
Genentech
Rituxan
Roche
Biogen Idec
non-Hodgkin's lymphoma
Phase III Study Showed Rituxan® for Initial Use Followed by Continued Use Delayed the Need for Additional Therapy in People with Asymptomatic Follicular Lymphoma, a Common Type of Blood Cancer
Yahoo/BusinessWire
Sun, 12/5/10 - 11:43 am
Rituxan
follicular lymphoma
Roche/Genentech
Biogen Idec
EMA: Few pharmas expected to tackle biosimilar antibodies
Fierce Biotech
Mon, 10/4/10 - 07:51 pm
biosimilars
EMA
Rituxan
Data from Combination of REVLIMID® and Rituxan® in Untreated Indolent B-Cell Non-Hodgkin's Lymphoma Presented at ASCO
Yahoo/BusinessWire
Sat, 06/5/10 - 09:59 am
non-Hodgkin's lymphoma
Revlimid
Rituxan
Cellgene
Healthcare Reform May Provide an Opportunity for Teva
Seeking Alpha
Thu, 05/27/10 - 10:27 am
healthcare reform
Teva Pharmaceuticals
Rituxan
biosimilars

Pages